{
    "title": "Lonza CEO departure prompts concern over earnings prospects",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12530431/Swiss-drug-ingredient-maker-Lonzas-CEO-leave.html",
    "date": "2023-09-18",
    "keywords": [
        "drug",
        "lonza",
        "profit",
        "burger",
        "illien",
        "executive",
        "ruffieux",
        "outlook",
        "biotech",
        "development",
        "cell",
        "gene",
        "contract",
        "manufacturer",
        "pierrealain",
        "company",
        "agreement",
        "end",
        "month",
        "investor",
        "confidence",
        "mediumterm",
        "strategy",
        "detail",
        "capital",
        "day",
        "chairman",
        "baehny",
        "ceo",
        "appointment",
        "successor",
        "healthcare",
        "gmt",
        "market",
        "trading",
        "stock",
        "july",
        "demand",
        "stage",
        "therapy",
        "time",
        "operating",
        "margin",
        "target",
        "roche",
        "role",
        "covid19",
        "moderna",
        "pandemic",
        "investment",
        "push",
        "part",
        "sale",
        "speciality",
        "business",
        "equity",
        "note",
        "equipment",
        "announcement",
        "conviction",
        "acceleration",
        "growth",
        "reason",
        "ruffieuxs",
        "departure",
        "spokespeople",
        "comment",
        "interest",
        "decade",
        "laboratory",
        "gear",
        "zurich",
        "frankfurt",
        "editing",
        "rachel",
        "goodman",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}